Contura Vet At ACVS 2025

2025 ACVS Surgery Summit

Seattle, WA | 22 – 25 October 2025

This year’s ACVS program features new Arthramid® data and translational insights that will directly shape the future of joint health across species.

See the latest data first: including new 0–84 day canine elbow OA results and equine osteoarthritis model findings.
Hear directly from leading experts like Dr. Matthew Brunke and Dr. Lisa Fortier as they present cutting-edge research.
Discover translational insights across the One Health continuum, linking human and veterinary joint care.
Stay ahead in orthopedics and regenerative medicine with evidence that’s reshaping treatment approaches for dogs, horses, and beyond.

Research Presented By:

Matthew Brunke DVM, DAVSMR, CCAT

Lisa A. Fortier DVM, PhD, DACVS

Katie Seabaugh DVM, DACVS, DACVSMR

Courtney A. Campbell, DVM, DACVS-SA

Presentation Details

Get access to three groundbreaking abstracts the moment they're unveiled

Physicochemical Properties of 2.5% iPAAG

Groundbreaking Reseach Unveiled at ACVS

This year’s ACVS Surgery Summit, taking place October 23–25, is one of the veterinary industry’s most influential forums, uniting surgeons, specialists, and researchers dedicated to advancing clinical excellence. The program highlights the latest innovations in orthopedics, sports medicine, and regenerative therapies, shaping the future of patient care across both small and large animals.

At the event, we’ll showcase groundbreaking Arthramid research, including new canine elbow OA data, an equine osteoarthritis model, and translational insights spanning the One Health continuum. These findings demonstrate how intra-articular polyacrylamide hydrogel (2.5% iPAAG) impacts synovitis, joint signaling, and osteoarthritis outcomes, setting a new standard for evidence-based joint health.